D-Mannoheptulose can be used as a hexokinase inhibitor (such as glucosamine) and can also be used to develop D-mannoheptose analogs for non-invasive imaging of pancreatic β cells.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.